Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity

Refinitiv阅读少于1分钟

Biophytis SA ALBPS:

BIOPHYTIS SA: OBTAINS EMA AUTHORIZATION TO LAUNCH ITS PHASE 2 CLINICAL TRIAL IN OBESITY - SEC FILING

阅读全文

在TradingView，您可以无限访问来自Reuters和所有其他新闻来源的文章。